Skip to content

Comparison the efficacy of ciprofol and propofol in painless gastroscopy in elderly patients with pre frailty

Comparison the efficacy of ciprofol and propofol in painless gastroscopy in elderly patients with pre frailty:A prospective randomized controlled study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600119117
Enrollment
Unknown
Registered
2026-02-23
Start date
2024-09-11
Completion date
Unknown
Last updated
2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None

Interventions

Cipropol Group:Cipropol 0.2 mg/kg+SUF(0.1ug/kg)
Propofol Group:Propofol 1 mg/kg+SUF(0.1ug/kg)

Sponsors

Chui Yang Liu Hospital affiliated to Tsinghua University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
65 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.Patients aged 65 years or older,female or male, who meet the criteria for pre frailty ; 2.American Society of Anesthesiologists classification(ASA) : I-III; 3.Plan to undergo painless gastroscopy examination at a scheduled time; 4.Signatory of informed consent form;

Exclusion criteria

Exclusion criteria: 1. There are contraindications to conventional endoscopic procedures or refusal of anesthesia; 2.Need for tracheal intubation and clear difficulties in the airway; 3.The patient has the following diseases: circulatory and respiratory diseases that are not properly controlled and may threaten life, severe liver dysfunction (Child Pugh C), severe renal dysfunction, acute upper gastrointestinal bleeding with shock, severe anemia, gastrointestinal obstruction with gastric retention; 4.Without accompanying or guardian; 5.Allergy to any component of the investigational drug, such as opioid drugs, propofol, cipropol and soy; 6.Concomitant severe neurological disorders such as epilepsy; 7.Unable to cooperate with severe mental illness; 8.Have a history of drug abuse; 9.Morbid obesity. 10.Those who do not cooperate or are unable to follow up;. 11.Patients deemed unsuitable by researchers.

Design outcomes

Primary

MeasureTime frame
Induction time;recovery time, and recovery time of orientation,;discharge time,;Drug dosage;the time of inserting gastroscopy;

Secondary

MeasureTime frame
Incidence rates of each aDuring surgery and before dischargedverse events;Hemodynamic changes at various time points;

Countries

China

Contacts

Public ContactYang Yanwei

Chui Yang Liu Hospital affiliated to Tsinghua University

yyw1980pg@sina.com+86 10 8777 7531

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Mar 14, 2026